Author:
Galsky Matthew D.,Mironov Svetlana,Iasonos Alexia,Scattergood Joseph,Boyle Mary G.,Bajorin Dean F.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Reference21 articles.
1. von der Maase H, Hansen SW, Roberts JT et al (2000) Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 18(17):3068–3077
2. Niyikiza C, Baker SD, Seitz DE et al (2002) Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapy. Mol Cancer Ther 1(7):545–552
3. Bunn P, Paoletti P, Niyikiza C et al (2001) Vitamin B12 and folate reduce toxicity of Alimta™ (Pemetrexed Disodium, LY231514, MTA), a Novel Antifolate/Antimetabolite. Proc Am Soc Clin Oncol 20:abstr #300
4. Sweeney CJ, Roth BJ, Kaufman DS, Nicol SJ (2003) Phase II study of pemetrexed for second-line treatment of transitional cell cancer of the bladder. Proc Am Soc Clin Oncol 22:abstr # 1653
5. Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European organization for research and treatment of cancer, National cancer institute of the United States, National cancer institute of Canada. J Natl Cancer Inst 92(3):205–216
Cited by
107 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献